CTOs on the Move

NeoMend

www.neomend.com

 
NeoMend is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.neomend.com
  • 60 Technology Dr
    Irvine, CA USA 92618
  • Phone: 949.916.1630

Executives

Name Title Contact Details

Similar Companies

Edgerton Hospital and Health Services

Edgerton Hospital and Health Services is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Edgerton, WI. To find more information about Edgerton Hospital and Health Services, please visit www.edgertonhospital.com

The Rothman Institute

The Rothman Institute is affiliated with Hospitals consisting of state-of-the-art facilities befitting world-class orthopaedic centers. Everything, from clinical and surgical centers, a fully equipped imaging area (with the latest MRI equipment) and a physical therapy center, to a pain management area, an orthotic center and research laboratories, libraries and an educational center is all under one roof.

Netwal Dental Laboratory Inc

Netwal Dental Laboratory Inc is a La Crosse, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sioux Center Community Hospital and Health Center

Sioux Center Community Hospital and Health Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Sioux Center Community Hospital and Health Center is based in Sioux Center, IA. You can find more information on Sioux Center Community Hospital and Health Center at www.schospital.org

Celator Pharmaceuticals

Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.